spacer
The Healthcare Sales & Marketing Network celebrates 28 years serving the medical sales & marketing community.Connecting Medical Sales Reps with MedTech/BioPharma Recruiters and Independent Reps with and New Product LinesConnecting Medical Sales Reps with MedTech/BioPharma Recruiters and Independent Reps with and New Product Lines

Healthcare News Roundup: Biopharmaceutical

 HSMN NewsFeed - 24 May 2018
IMBRUVICA(R) (ibrutinib) Plus GAZYVA(R) (obinutuzumab) Phase 3 iLLUMINATE Trial for First-Line Therapy of Chronic Lymphocytic Leukemia (CLL) Patients Met Primary Endpoint
Biopharmaceuticals Oncology
 HSMN NewsFeed - 24 May 2018
Curis Expands Senior Management Expertise with Appointment of Robert Martell, M.D., Ph.D., as Head of Research and Development
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 23 May 2018
mAbxience and Amneal Enter Into an Agreement for Bevacizumab Biosimilar in the United States
Biopharmaceuticals Generics Licensing
 HSMN NewsFeed - 18 May 2018
Apexigen Expands Leadership Team With Appointment Of Frances Rena Bahjat, Ph.D. Vice President, Discovery Research
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 18 May 2018
FDA Approves Aimovig(TM) (erenumab-aooe), A Novel Treatment Developed Specifically For Migraine Prevention
Biopharmaceuticals Devices Drug Delivery FDA
 HSMN NewsFeed - 17 May 2018
Statement from FDA Commissioner Scott Gottlieb, M.D., on new agency efforts to shine light on situations where drug makers may be pursuing gaming tactics to delay generic competition
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 17 May 2018
ImaginAb Reconstitutes Scientific Advisory Board
Biopharmaceuticals Oncology Radiology Personnel
 HSMN NewsFeed - 17 May 2018
Correvio Announces Enrollment of First Patient in Phase 3 Study Evaluating Brinavess(R) in China
Biopharmaceuticals Cardiology
 HSMN NewsFeed - 16 May 2018
FogPharma Secures $66 Million Series B Financing
Biopharmaceuticals Venture Capital Personnel
 HSMN NewsFeed - 16 May 2018
Eiger Announces Expanded License Agreement with Merck for Investigational Candidate Lonafarnib and Collaboration with The Progeria Research Foundation (PRF)
Biopharmaceuticals Licensing Distribution
 HSMN NewsFeed - 16 May 2018
Protagonist Therapeutics Appoints Bryan Giraudo to Board of Directors
Biopharmaceuticals Gastroenterology Personnel
 HSMN NewsFeed - 16 May 2018
Roivant Expands Senior Leadership with Key Hires
Biopharmaceuticals Personnel
 HSMN NewsFeed - 16 May 2018
EIP Pharma Secures $20.5 Million in Series B Financing
Biopharmaceuticals Neurology Venture Capital
 HSMN NewsFeed - 16 May 2018
TapImmune Creates Scientific Advisory Board to Support Clinical Development of Multi-Antigen Cell Therapy Platform
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 16 May 2018
Positive Phase 3 Trial of DUPIXENT(R) (dupilumab) in Adolescents with Inadequately Controlled Moderate-to-severe Atopic Dermatitis
Biopharmaceuticals Dermatology
 HSMN NewsFeed - 15 May 2018
Medicinal Chemistry Leaders Drs. Phil Carpino and Mike Genin Form New Chemistry Team at Recursion Pharmaceuticals
Biopharmaceuticals Personnel
 HSMN NewsFeed - 15 May 2018
Amneal Introduces First Generic for Mephyton(R) (Phytonadione) Tablets, 5mg
Biopharmaceuticals Generics Product Launch
 HSMN NewsFeed - 15 May 2018
Surface Pharmaceuticals, Inc. Announces $20 Million Series A Financing from Flying L Partners
Biopharmaceuticals Ophthalmology Venture Capital
 HSMN NewsFeed - 15 May 2018
Lilly's Galcanezumab Meets Primary Endpoint in Phase 3 Study Evaluating Galcanezumab for the Prevention of Episodic Cluster Headache
Biopharmaceuticals Neurology
 HSMN NewsFeed - 14 May 2018
Ansun BioPharma secures $85 million in Series A Financing
Biopharmaceuticals Venture Capital Personnel
 HSMN NewsFeed - 14 May 2018
Aquestive Therapeutics Settles Patent Infringement Case with Par Pharmaceuticals
Biopharmaceuticals Drug Delivery Generics Litigation
 HSMN NewsFeed - 14 May 2018
GT Biopharma Announces Dr. Raymond W Urbanski Elevated to President and Chief Medical Officer of the Company
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 14 May 2018
Lilly to Acquire AurKa Pharma
Biopharmaceuticals Oncology Mergers & Acquisitions
 HSMN NewsFeed - 14 May 2018
Accomplished Global Pharmaceutical Executive, Federico Seghi Recli, Appointed To Titan's Board
Biopharmaceuticals Drug Delivery Personnel
 HSMN NewsFeed - 10 May 2018
Aldeyra Therapeutics Appoints David McMullin as Senior Vice President, Corporate Development and Strategy
Biopharmaceuticals Ophthalmology Personnel
 HSMN NewsFeed - 10 May 2018
Lilly Announces Agreement To Acquire ARMO BioSciences
Biopharmaceuticals Oncology Mergers & Acquisitions
 HSMN NewsFeed - 9 May 2018
DURECT Announces Amendment to Licensing Agreement with Sandoz Related to POSIMIR(R) (SABER(R)-Bupivacaine)
Biopharmaceuticals Drug Delivery Surgery Licensing
 HSMN NewsFeed - 8 May 2018
Pliant Therapeutics Appoints Hoyoung Huh as Chairman and Éric Lefebvre as Chief Medical Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 8 May 2018
Valeant Will Become Bausch Health Companies Inc.
Biopharmaceuticals Dermatology
 HSMN NewsFeed - 8 May 2018
TFF Pharmaceuticals Announces Appointment of Glenn Mattes as New Chief Executive Officer
Biopharmaceuticals Drug Delivery Personnel
 HSMN NewsFeed - 8 May 2018
Daiichi Sankyo Announces Single Agent Quizartinib Significantly Prolongs Overall Survival Compared with Chemotherapy in Patients with Relapsed/Refractory AML with FLT3-ITD Mutations (QuANTUM-R Study)
Biopharmaceuticals Oncology
 HSMN NewsFeed - 7 May 2018
ORIC Has Appointed Jacob Chacko, MD as Chief Executive Officer
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 7 May 2018
ANI Pharmaceuticals Completes Acquisition of Generic Products and Assets from Amneal/Impax
Biopharmaceuticals Generics Acquisitions
 HSMN NewsFeed - 7 May 2018
Genprex Announces $10 Million Private Placement
Biopharmaceuticals Oncology Venture Capital
 HSMN NewsFeed - 7 May 2018
Amneal Initiates Phase 3 Study for IPX203, an Investigational Extended-Release Formulation of Carbidopa-Levodopa (CD-LD) in Advanced Parkinson's Disease Patients
Biopharmaceutical Neurology
 HSMN NewsFeed - 7 May 2018
Salix Receives FDA Approval For PLENVU(R), Next Generation 1-Liter Bowel Cleansing Preparation For Colonoscopies
Biopharmaceuticals Radiology Gastroenterology FDA
 HSMN NewsFeed - 7 May 2018
Lannett Acquires Portfolio Of Generic Products From Endo International
Biopharmaceuticals Generic Acquisitions
 HSMN NewsFeed - 4 May 2018
InDex Pharmaceuticals Develops Oral Formulation of Cobitolimod
Biopharmaceuticals Gastroenterology
 HSMN NewsFeed - 3 May 2018
CytRx Corporation Names Eric L. Curtis as Its President and Chief Operating Officer
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 3 May 2018
Aptinyx Promotes David Houck to Chief Development Officer
Biopharmaceuticals Neurology Personnel
 HSMN NewsFeed - 3 May 2018
GigaGen Announces Appointment of Sheila M. Keating, Ph.D., as Director, Immunology
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 3 May 2018
Topix Pharmaceuticals Launches Game Changing Treatment Cream For Extremely Dry Skin
Biopharmaceuticals Dermatology Product Launch
 HSMN NewsFeed - 2 May 2018
Aquestive Therapeutics Appoints Nancy Lurker to Board of Directors
Biopharmaceuticals Drug Delivery Neurology Personnel
 HSMN NewsFeed - 2 May 2018
Refuge Biotechnologies Completes $25 Million Series B Financing, Appoints CSO to Advance the Development of Intelligent Cell Therapies in Oncology
Biopharmaceuticals Oncology Venture Capital Personnel
 HSMN NewsFeed - 1 May 2018
SCYNEXIS's Oral SCY-078 Receives FDA QIDP and Fast Track Designations for the Treatment of VVC and Prevention of Recurrent VVC
Biopharmaceuticals FDA
 HSMN NewsFeed - 1 May 2018
Pharmaceutical Business Development Leader Dr. Kevin Lynch Joins Recursion as Chief Business Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 1 May 2018
Regeneron and Sanofi to Lower Net Price of Praluent(R) (alirocumab) Injection in Exchange for Straightforward, More Affordable Patient Access for Express Scripts Patients
Biopharmaceuticals Reimbursement
 HSMN NewsFeed - 30 Apr 2018
Actelion Submits Supplemental New Drug Application to US FDA Seeking Approval of OPSUMIT(R) (macitentan) for the Treatment of Chronic Thromboembolic Pulmonary Hypertension (CTEPH)
Biopharmaceuticals FDA
 HSMN NewsFeed - 30 Apr 2018
Attenua Raises $35M in Series A Financing to Advance Therapy for Chronic Cough
Biopharmaceuticals Venture Capital Personnel
 HSMN NewsFeed - 30 Apr 2018
Forty Seven Inc. Appoints Ian T. Clark to Board of Directors
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 30 Apr 2018
Synthorx Announces $63 Million Series C Financing to Advance a Pipeline of Synthorin(TM) Cytokines
Biopharmaceuticals Oncology Venture Capital
 HSMN NewsFeed - 30 Apr 2018
Adicet Bio appoints Elizabeth "EJ" Read, M.D. as Chief Technology Officer
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 30 Apr 2018
United Therapeutics To Acquire SteadyMed Ltd.
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 30 Apr 2018
FDA to Conduct Priority Review of Cemiplimab as a Potential Treatment for Advanced Cutaneous Squamous Cell Carcinoma
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 27 Apr 2018
Amgen Receives Positive CHMP Opinion To Expand Use Of Prolia(R) (denosumab) To Patients With Glucocorticoid-Induced Osteoporosis
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 27 Apr 2018
AcelRx receives positive CHMP opinion for DZUVEO(TM) for management of acute moderate to severe pain in medically monitored settings
Biopharmaceutical Drug Delivery Regulatory
 HSMN NewsFeed - 27 Apr 2018
Moberg Pharma Completes Divestment of Balmex(R) for $4.25 million
Biopharmaceuticals Acquisitions
 HSMN NewsFeed - 26 Apr 2018
Seasoned Financial Executive Federica O'Brien Joins GT Biopharma's Board of Directors
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 26 Apr 2018
Endo to Acquire Somerset Therapeutics and Business of Affiliate Wintac Limited
Biopharmaceuticals Ophthalmology Mergers & Acquisitions
 HSMN NewsFeed - 26 Apr 2018
Neuraltus Pharmaceuticals Reports Results from Phase 2 NP001 Study in Amyotrophic Lateral Sclerosis (ALS)
Biopharmaceuticals Neurology
 HSMN NewsFeed - 25 Apr 2018
FDA Grants Fast Track Designation for OrphoMed's ORP-101 for Treatment of IBS-D
Biopharmaceuticals Gastroenterology FDA
 HSMN NewsFeed - 25 Apr 2018
Juniper Pharmaceuticals Licenses Intravaginal Ring (IVR) Platform to Daré Bioscience
Biopharmaceutical Drug Delivery Licensing
 HSMN NewsFeed - 25 Apr 2018
Dermtreat Appoints Nishan de Silva, M.D., as CEO; Establishes North American Headquarters in San Diego
Biopharmaceuticals Dermatology Personnel
 HSMN NewsFeed - 25 Apr 2018
MaxCyte Appoints Dr. Claudio Dansky Ullmann as Chief Medical Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 25 Apr 2018
Lilly and China's NCCD announce collaboration to advance scientific understanding and care for people living with diabetes and cardiovascular disease
Biopharmaceuticals Cardiology Endocrinology
 HSMN NewsFeed - 25 Apr 2018
Novartis launches FocalView app, providing opportunity for patients to participate in ophthalmology clinical trials from home
Biopharmaceuticals Ophthalmology Product Launch
 HSMN NewsFeed - 24 Apr 2018
Lin BioScience Announces FDA Orphan Drug Designation for LBS-007 for the Treatment of Acute Lymphoblastic Leukemia
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 24 Apr 2018
Former Sucampo Chief Scientific Officer, Dr. Peter Kiener, Joins GT Biopharma's Board of Directors
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 24 Apr 2018
Aldeyra Therapeutics Announces First Patient Enrolled in Allergic Conjunctivitis Phase 3 Clinical Trial
Biopharmaceuticals Ophthalmology
 HSMN NewsFeed - 24 Apr 2018
Urovant Sciences Strengthens Executive Management Team with Senior Hires and Establishes U.S. Headquarters in Irvine, California
Biopharmaceuticals Urology Personnel
 HSMN NewsFeed - 24 Apr 2018
AAN 2018: Lilly's Galcanezumab Significantly Reduced Monthly Migraine Headache Days in Patients with Migraine Who Previously Failed to Respond to Multiple Preventive Therapies
Biopharmaceuticals Neurology
 HSMN NewsFeed - 23 Apr 2018
Amerigen and Dipharma Announce U.S. FDA Approval for Generic Miglustat 100 mg Capsules
Biopharmaceuticals Generics FDA Product Launch
 HSMN NewsFeed - 23 Apr 2018
OrphoMed Appoints Gary M. Phillips, M.D. as President and Chief Executive Officer
Biopharmaceuticals Gastroenterology Personnel
 HSMN NewsFeed - 23 Apr 2018
Clarus Appoints Former Ariad CEO Paris Panayiotopoulos as Operating Partner and Member of its Investment Team
Biopharmaceuticals Venture Capital Personnel
 HSMN NewsFeed - 23 Apr 2018
Theravance Biopharma Reports Positive New Data from Multiple Studies of VIBATIV(R) (telavancin) at 2018 ECCMID(TM) Conference
Biopharmaceuticals
 HSMN NewsFeed - 23 Apr 2018
Dr. Philip Just Larsen Appointed Chief Scientific Officer (CSO)
Biopharmaceuticals Personnel
 HSMN NewsFeed - 20 Apr 2018
Helsinn Group announces the FDA approval of the IV formulation of AKYNZEO(R) (fosnetupitant/ palonosetron) in the United States
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 20 Apr 2018
SELLAS Life Sciences Announces Appointment of Gene Mack as Chief Financial Officer & Treasurer
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 20 Apr 2018
FDA Accepts Veloxis's Supplemental New Drug Application for the De Novo Indication for ENVARSUS XR(R)
Biopharmaceuticals FDA
 HSMN NewsFeed - 20 Apr 2018
UCB to Expand Epilepsy Portfolio With Strategic Acquisition of Midazolam Nasal Spray From Proximagen
Biopharmaceuticals Neurology Acquisitions
 HSMN NewsFeed - 20 Apr 2018
Lannett Names Maureen Cavanaugh Senior Vice President And Chief Commercial Operations Officer
Biopharmaceuticals Generics Personnel
 HSMN NewsFeed - 19 Apr 2018
Tocagen and ApolloBio Enter License Agreement to Develop and Commercialize Toca 511 & Toca FC in the Greater China Region
Biopharmaceuticals Oncology Licensing
 HSMN NewsFeed - 19 Apr 2018
Management Change in Moberg Pharma
Biopharmaceuticals Personnel
 HSMN NewsFeed - 18 Apr 2018
Tetherex Pharmaceuticals, Inc. Completes $50M Series B Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 17 Apr 2018
Cardiome Completes Enrollment in the Post Approval Safety Study SPECTRUM Evaluating Brinavess(R)
Biopharmaceuticals Cardiology
 HSMN NewsFeed - 16 Apr 2018
Apitope Announces Positive Results with Novel Treatment for Graves' Disease
Biopharmaceuticals
 HSMN NewsFeed - 13 Apr 2018
Cellenkos, Inc. Announces Alick Sun as Senior Vice President for Corporate and Business Development
Biopharmaceuticals Personnel
 HSMN NewsFeed - 13 Apr 2018
Ampio Updates Regulatory, Clinical and NYSE Activities
Biopharmaceuticals FDA
 HSMN NewsFeed - 11 Apr 2018
Genprex Appoints Julien Pham, MD, MPH As President To Lead Commercialization Of Oncoprex Immunogene Therapy
Biopharmaceuticals Oncology Drug Delivery Personnel
 HSMN NewsFeed - 11 Apr 2018
RubrYc Therapeutics Completes $10M Million Series A Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 11 Apr 2018
InMed Announces Appointment of Joshua Blacher as Chief Business Officer
Biopharmaceuticals Drug Delivery Personnel
 HSMN NewsFeed - 11 Apr 2018
Macrophage Pharma Appoints Dr Michael Moore as Chairman
Biopharmaceuticals Personnel
 HSMN NewsFeed - 10 Apr 2018
TCR2 Therapeutics Appoints Leading Biotech Analyst Ian Somaiya as Chief Financial Officer
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 10 Apr 2018
Mylan to Acquire the Global Marketing Rights to a Once-monthly Glatiramer Acetate Product through an Investment and Partnership with Israeli Company Mapi Pharma
Biopharmaceuticals Neurology Acquisitions
 HSMN NewsFeed - 10 Apr 2018
Former CoLucid CEO Thomas P. Mathers joins Pappas Capital as Partner
Biopharmaceuticals Venture Capital Personnel
 HSMN NewsFeed - 9 Apr 2018
Cumberland Pharmaceuticals Expands into Oncology Support
Biopharmaceuticals Oncology Licensing Distribution
 HSMN NewsFeed - 9 Apr 2018
Intezyne Promotes Adam Carie, PhD to Director, Product Development
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 9 Apr 2018
RegeneRx Announces Outcome of FDA Discussions for Development of RGN-259 for Dry Eye Syndrome
Biopharmaceuticals Ophthalmology FDA
 HSMN NewsFeed - 6 Apr 2018
Teligent, Inc. Announces FDA Approval of Ciclopirox Shampoo, 1%
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 6 Apr 2018
Impax Launches a Generic Version of Estrace(R) Cream (estradiol vaginal cream, USP, 0.01%)
Biopharmaceuticals Generics Product Launch
 HSMN NewsFeed - 5 Apr 2018
AbbVie Announces Global Resolution of HUMIRA(R) (adalimumab) Patent Disputes with Samsung Bioepis
Biopharmaceuticals Litigation Licensing
 HSMN NewsFeed - 5 Apr 2018
Eidos Therapeutics completes $64M Series B financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 4 Apr 2018
Arvinas Completes $55 Million Series C Financing to Advance Protein Degradation Platform
Biopharmaceuticals Venture Capital Personnel
 HSMN NewsFeed - 4 Apr 2018
Abide Therapeutics Appoints Thomas C. Südhof to Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 4 Apr 2018
Lilly and Sigilon Therapeutics Announce Strategic Collaboration to Develop Encapsulated Cell Therapies for the Treatment of Type 1 Diabetes
Biopharmaceuticals Endocrinology Licensing
 HSMN NewsFeed - 4 Apr 2018
Angus Russell to Succeed Melvin Booth as Mallinckrodt Chairman of the Board in May 2018
Biopharmaceuticals Personnel
 HSMN NewsFeed - 4 Apr 2018
Mallinckrodt Names Paul R. Carter, Anne C. Whitaker to its Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 4 Apr 2018
Proteostasis Therapeutics Receives FDA Fast Track Designation for Triple Combination Program in Patients with Cystic Fibrosis
Biopharmaceuticals FDA
 HSMN NewsFeed - 3 Apr 2018
Oncternal Therapeutics Further Strengthens Leadership with Additions to Board of Directors
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 3 Apr 2018
Dr. Ottavio Vitolo Joins Relmada Therapeutics as Senior Vice President, Head of R&D and Chief Medical Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 3 Apr 2018
Bridge Medicines Appoints Louis M. Renzetti, Ph.D., As Chief Scientific Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 3 Apr 2018
Biopharm Startup TFF Pharmaceuticals Raises $14M for Breakthrough Dry Powder Inhalation Platform
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 3 Apr 2018
Kleo Pharmaceuticals Inc. Appoints Luca Rastelli, PhD as Chief Scientific Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 2 Apr 2018
INSYS Therapeutics Appoints Trudy Vanhove to Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 2 Apr 2018
Abeona Therapeutics Appoints Carsten Thiel, Ph.D., as Chief Executive Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 2 Apr 2018
Endo Agrees to Extend Temporary Stay of FDA Litigation
Biopharmaceuticals FDA Litigation
 HSMN NewsFeed - 2 Apr 2018
Compugen Announces Exclusive License Agreement With MedImmune for the Development of Bi-Specific and Multi-Specific Antibody Products
Biopharmaceuticals Oncology Licensing
 HSMN NewsFeed - 2 Apr 2018
Duchesnay USA Announces Launch of Bonjesta(R) (doxylamine succinate - pyridoxine hydrochloride) in the United States
Biopharmaceuticals Product Launch
Older Biopharmaceutical stories   Return to NewsFeed  
FindReps - screen and connect with rep candidates anonymously, in real time.

FindReps: Screen and connect with Medical Sales Rep candidates (Direct Reps and Independents) – anonymously, in real time.


RepJobs - Job Opportunities for Direct Sales Reps and New Product Lines for Independents!

RepJobs: Job Opportunities for Direct Sales Reps and New Product Lines for Independents!